Finance

Beta
Lists
OPK:NASDAQ
OPKO Health Inc
$1.44
-1.37%
(-0.020) 1D
$1.46
+1.39% (+0.020)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OPK...
Open
$1.47
High
$1.55
Low
$1.43
Mkt. cap
1.09B
Avg. vol.
2.74M
Volume
3.95M
52-wk high
$1.60
52-wk low
$0.98
EPS
-$0.27
Beta
1.50
Shares outstanding
755.09M
No. of employees
2K
Open
$1.47
High
$1.55
Low
$1.43
Mkt. cap
1.09B
Avg. vol.
2.74M
Volume
3.95M
52-wk high
$1.60
52-wk low
$0.98
EPS
-$0.27
Beta
1.50
Shares outstanding
755.09M
No. of employees
2K
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to OPK in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for OPK in the last 3 months.
Highest
Current $1.44
$3.00 (+108.33%)
Average
$3.00 (+108.33%)
Lowest
$3.00 (+108.33%)
News stories
From sources across the web
About OPKO Health Inc
CEO-
Employees2.28K
Founded1991
HeadquartersMiami, Florida, United States
SectorHealth care provider
Websiteopko.com
Last report
Apr 28, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.07 / -$0.08
+12.50%beat
Revenue / Est. (USD)
124.20M / 130.77M
-5.02%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
156.81M
151.67M
148.45M
124.20M
Cost of goods sold
137.75M
131.85M
117.20M
107.64M
Cost of revenue
137.75M
131.85M
117.20M
107.64M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
59.60M
53.80M
55.22M
48.61M
Operating expense
79.04M
73.34M
74.27M
67.57M
Total operating expenses
216.79M
205.19M
191.47M
175.21M
Operating income
-59.98M
-53.52M
-43.02M
-51.02M
Other non operating income
-32.90M
610.00K
-354.00K
139.00K
EBT including unusual items
-162.52M
41.43M
-46.92M
-60.96M
EBT excluding unusual items
-162.52M
-60.15M
-51.38M
-57.31M
Income tax expense
-14.08M
19.80M
-15.66M
-6.11M
Effective tax rate
8.66%
47.79%
33.38%
10.02%
Other operating expenses
-
-
-
-
Net income
-148.44M
21.63M
-31.26M
-54.85M
Net profit margin
-94.66%
14.26%
-21.06%
-44.16%
Earnings per share
-0.08
-
-0.04
-
Interest and investment income
3.29M
3.02M
3.82M
3.01M
Interest expense
-70.33M
-11.36M
-11.31M
-10.94M
Net interest expenses
-67.04M
-8.34M
-7.49M
-7.93M
Depreciation and amortization charges
-
-
-
-
EBITDA
-36.95M
-30.78M
-20.64M
-28.82M
Gain or loss from assets sale
-72.00K
-101.56M
601.00K
-34.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more